These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1706791)

  • 41. Quinidine administration increases steady state serum digoxin concentration in horses.
    Parraga ME; Kittleson MD; Drake CM
    Equine Vet J Suppl; 1995 Sep; (19):114-9. PubMed ID: 8933078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of AN-132 and quinidine, antiarrhythmic agents, on plasma digoxin concentrations in rats.
    Sakai K; Yamazaki T; Hinohara Y
    J Pharm Pharmacol; 1988 Jan; 40(1):68-9. PubMed ID: 2896782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Digoxin-quinidine interaction in the dog.
    De Rick A; Belpaire F
    J Vet Pharmacol Ther; 1981 Sep; 4(3):215-8. PubMed ID: 7349336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac glycoside interactions at 'silent' and at active receptors. Putative biochemical backgrounds and possible clinical relevance.
    Offerhaus L
    Neth J Med; 1985; 28(10):393-400. PubMed ID: 3001546
    [No Abstract]   [Full Text] [Related]  

  • 45. Reduction of digoxin-induced inotropism during quinidine administration.
    Steiness E; Waldorff S; Hansen PB; Kjaergård H; Buch J; Egeblad H
    Clin Pharmacol Ther; 1980 Jun; 27(6):791-5. PubMed ID: 7379447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Digoxin-amiodarone interaction].
    Strocchi E; Malini PL; Graziani A; Ambrosioni E; Magnani B
    G Ital Cardiol; 1984 Jan; 14(1):12-5. PubMed ID: 6706051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions between quinidine and cardiac glycosides involving mutual binding sites in the guinea pig.
    Kim DH; Akera T; Brody TM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):108-14. PubMed ID: 6264063
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of quinidine on the renal tubular and biliary transport of digoxin: in vivo and in vitro studies in the dog.
    Koren G; Klein J; Giesbrecht E; Ben Dayan R; Soldin S; Sellers E; MacLeod S; Silverman M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1193-8. PubMed ID: 3204514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.
    Bauer LA; Horn JR; Pettit H
    Ther Drug Monit; 1996 Feb; 18(1):46-52. PubMed ID: 8848820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle.
    Jogestrand T; Schenck-Gustafsson K; Nordlander R; Dahlqvist R
    Eur J Clin Pharmacol; 1984; 27(5):571-5. PubMed ID: 6519162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced clearance of specifically bound digoxin from human myocardial and skeletal muscle samples by specific digoxin antibody fragments: subsequent complete digitalis glycoside receptor (Na,K-ATPase) quantification.
    Schmidt TA; Kjeldsen K
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):670-7. PubMed ID: 1711637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling cardiac uptake and negative inotropic response of verapamil in rat heart: effect of amiodarone.
    Sermsappasuk P; Abdelrahman O; Weiss M
    Pharm Res; 2007 Jan; 24(1):48-57. PubMed ID: 16969694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of [3H]-nitrendipine and [3H]-diltiazem to rat myocardial sarcolemma.
    Miwa N; Kanaide H; Nishimura J; Nakamura M
    Arzneimittelforschung; 1986 Jul; 36(7):1059-62. PubMed ID: 3021180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R; Nilsson B
    Clin Pharmacol Ther; 1990 Jan; 47(1):20-6. PubMed ID: 2295215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of quinidine on the renal clearance of digoxin in the presence of low and high serum digoxin concentrations.
    Clohisy DR; Quintanilla AP; Gibson TP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):49-51. PubMed ID: 7086708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptor radioligand system for measuring digoxin activity.
    Manchester EL; Giesbrecht E; Soldin SJ
    Ther Drug Monit; 1987; 9(1):61-6. PubMed ID: 3033851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Digoxin-quinidine interaction. Changes in canine tissue concentration from steady state with quinidine.
    Doherty JE; Straub KD; Murphy ML; de Soyza N; Bissett JK; Kane JJ
    Am J Cardiol; 1980 Jun; 45(6):1196-200. PubMed ID: 7377118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of quinidine on digoxin bioavailability.
    Pedersen KE; Christiansen BD; Klitgaard NA; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 24(1):41-7. PubMed ID: 6832200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of quinidine on the tissue binding of digoxin in guinea-pigs.
    Okudaira K; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Pharmacol; 1986 Feb; 38(2):137-40. PubMed ID: 2870160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.